U.S. markets close in 1 hour 56 minutes
  • S&P 500

    3,281.98
    +35.39 (+1.09%)
     
  • Dow 30

    27,035.15
    +219.71 (+0.82%)
     
  • Nasdaq

    10,850.25
    +177.98 (+1.67%)
     
  • Russell 2000

    1,470.38
    +18.56 (+1.28%)
     
  • Crude Oil

    40.25
    -0.06 (-0.15%)
     
  • Gold

    1,868.50
    -8.40 (-0.45%)
     
  • Silver

    23.17
    -0.02 (-0.09%)
     
  • EUR/USD

    1.1632
    -0.0043 (-0.37%)
     
  • 10-Yr Bond

    0.6590
    -0.0070 (-1.05%)
     
  • GBP/USD

    1.2722
    -0.0030 (-0.24%)
     
  • USD/JPY

    105.5970
    +0.1950 (+0.19%)
     
  • BTC-USD

    10,708.02
    -52.57 (-0.49%)
     
  • CMC Crypto 200

    219.47
    +1.64 (+0.75%)
     
  • FTSE 100

    5,842.67
    +19.89 (+0.34%)
     
  • Nikkei 225

    23,204.62
    +116.80 (+0.51%)
     

Cutera Reports Fourth Quarter and Full Year 2018 Financial Results

Total truSculpt® Body Sculpting Generated 32% Revenue Growth in 2018

BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reports financial results for the fourth quarter and fiscal year ended December 31, 2018.

Key financial and operational highlights for the fourth quarter and full year 2018 include:

  • Revenue for the fourth quarter increased 12% sequentially, though decreased 5% from the prior year fourth quarter, to $45.5 million. Revenue increased 7% to $162.7 million for the full year 2018; 
    -- Fourth quarter continues to reflect strong demand for the body sculpting product portfolio, truSculpt, with the number of systems sold growing strong double digits both sequentially and year over year. 
    -- Total recurring revenue, which includes service, skincare and consumable revenue, for the fourth quarter reached $8.6 million, or 28% growth over the fourth quarter 2017.  For the full year 2018, total recurring revenue was $30.1 million, or 18% growth over the full year 2017.
    -- US revenue declined by 7% in the fourth quarter over the prior year period, and increased 8% for the full year 2018. Results reflect strong demand for the truSculpt and Secret RF systems, primarily offset by softness in the overall women’s health market, competitive trends affecting certain legacy systems, and greater than expected turnover in our North American salesforce in the fourth quarter.
    -- International revenue grew 1% in the fourth quarter and 7% for the full year 2018. Full year results reflect double-digit growth in the Middle East and Asia (excluding Japan).

  • Gross Margin for the fourth quarter was 41%, compared to 57% in the prior year period. For the full year 2018, gross margin was 49% versus 57% for the prior year. The decrease in fourth quarter gross margin reflects pricing headwinds across the portfolio of legacy systems, channel mix, and a $5.0 million charge, of which $1.1 million was utilized in the fourth quarter. This charge related to product remediation of one of our legacy systems. Non-GAAP gross margin* was 53% for both the fourth quarter and full year 2018, compared to 58% and 57% for the respective prior year periods.

  • Operating expenses for the fourth quarter and full year 2018 were 53% and 58% of revenue, respectively. This compares to 48% and 50% for the prior year periods.  Non-GAAP* operating expenses for the fourth quarter and full year 2018 were 48% and 52% of revenue, respectively, as compared to 45% and 49% for the same prior year periods.

  • GAAP Net Loss for the fourth quarter and full year 2018 was $26.3 million and $30.8 million, or $1.89 and $2.23 loss per share on a basic and fully-diluted basis.  GAAP net loss includes a valuation allowance of $16.9 million against certain U.S. deferred tax assets in the fourth quarter. The recording of the valuation allowance resulted in a GAAP income tax provision of $20.8 million in the fourth quarter of 2018.  Non-GAAP* net income for full year 2018 was $1.5 million, or $0.11 per fully-diluted share.

“2018 was a year of achievements and challenges. Cutera launched four new products, including our next-generation body contouring system, truSculpt iD, which we expect to be a meaningful platform in this billion-dollar market. In addition, we continue to make progress streamlining multiple manufacturing and inventory processes, further enhancing our future growth,’ stated Cutera Chief Operating Officer and Interim CEO, Jason Richey. “Like others in the aesthetic space, we encountered considerable headwinds affecting our overall results in the second half of 2018. As interim CEO, and with the full support of the Board of Directors, my priorities are clear --- position Cutera to grow faster than the market without sacrificing profitability, while improving the efficiencies of the Company’s infrastructure. We are executing on multiple initiatives in order to achieve these goals and I am optimistic about the Company’s future. I look forward to reporting our future progress.”

2019 Financial Outlook

  • We expect full year revenue to be in the range of $165 to $175 million, a 2% - 8% increase over 2018;

  • Full year Non-GAAP* gross margin is expected to improve over 2018 full year Non-GAAP* gross margin;

  • Adjusted EBITDA* is expected to be in the range of $2 million to $4 million.

Conference Call

The Company will host a live audio webcast for interested parties commencing today at 1:30 p.m. PST (4:30 p.m. EST).  Participating in the call will be Jason Richey, Chief Operating Officer and Interim Chief Executive Officer and Sandra Gardiner, Executive Vice President and Chief Financial Officer.  The call will be broadcast live over the Internet, hosted at the Investor Relations section of Cutera's website at http://www.cutera.com/, and will be available online within 24 hours of its completion through May 20, 2019. In addition, you may call 1-877-705-6003 to listen to the live broadcast.

CONTACTS:

Cutera, Inc.
Matthew Scalo
Vice President, Investor Relations & Corporate Development
415-657-5500
mscalo@cutera.com

Investor Relations
John Mills
Partner, ICR, Inc.
646-277-1254
john.mills@icrinc.com

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

*Use of Non-GAAP Financial Measures

In this press release, in order to supplement our condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share.  Non-GAAP adjustments include stock-based compensation, depreciation, amortization, product remediation charges, and Enterprise Resource Planning (“ERP”) system implementation costs, as well as the net tax impact of excluding these items.  From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.  We have provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure.  We have not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability, limited visibility, unpredictability, or unique non-recurring nature of the items. Forward-looking non-GAAP measures include adjusted EBITDA.  We define adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, product remediation charges outside the scope of our typical recurring warranty and service costs, and charges related to ERP software implementation costs.

Company management uses these measurements as aids in monitoring the Company’s ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP.  Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

Non-cash expenses for stock-based compensation. We have excluded the effect of stock-based compensation expenses in calculating our non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to our employees, we continue to evaluate our business performance excluding stock-based compensation expenses. We record stock-based compensation expense related to grants of options, performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods.  We believe that excluding stock-based compensation better allows for comparisons to our peer companies;

Depreciation and amortization. We have excluded depreciation and amortization expense in calculating our non-GAAP operating expenses and net income measures.  Depreciation and amortization are non-cash charges to current operations;

Product Remediation. We have excluded costs incurred to remediate an issue related to a legacy product.  These costs include the repair of products in use, in inventory, and in production, and are outside the scope of our typical recurring warranty and service costs; and

Enterprise Resource Planning. We have excluded ERP system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new ERP solution and the related technology infrastructure costs.

We believe that excluding all of the items above allows users of our financial statements to better review and assess both current and historical results of operations.

Safe Harbor Statement

Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, but are not limited to, Cutera’s plans, objectives, strategies, financial performance and outlook, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, our actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee” or variations of these terms and similar expressions, or the negative of these terms or similar expressions.  Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera.

All information in this press release is as of the date of its release.  Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the fourth quarter and full year ended December 31, 2018, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

 

CUTERA, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in thousands)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

September 30,

 

 

December 31,

 

 

 

 

 

 

2018

 

 

2018

 

 

2017(1)

 

Assets

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

26,052

 

$

21,866

 

$

14,184

 

 

Marketable investments

 

 

9,523

 

 

5,018

 

 

21,728

 

 

Accounts receivable, net

 

 

19,637

 

 

25,444

 

 

20,777

 

 

Inventories

 

 

28,014

 

 

31,322

 

 

28,782

 

 

Other current assets and prepaid expenses

 

 

3,972

 

 

3,716

 

 

2,903

 

 

 

Total current assets

 

 

87,198

 

 

87,366

 

 

88,374

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

2,672

 

 

2,784

 

 

2,096

 

Deferred tax asset

 

 

457

 

 

21,402

 

 

19,055

 

Goodwill

 

 

1,339

 

 

1,339

 

 

1,339

 

Other long-term assets

 

 

5,971

 

 

6,048

 

 

374

 

 

 

Total assets

 

$

97,637

 

$

118,939

 

$

111,238

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

11,279

 

$

13,321

 

$

7,002

 

 

Accrued liabilities

 

 

23,300

 

 

22,904

 

 

26,848

 

 

Extended warranty liabilities

 

 

3,159

 

 

-

 

 

-

 

 

Deferred revenue

 

 

9,882

 

 

8,939

 

 

9,461

 

 

 

Total current liabilities

 

 

47,620

 

 

45,164

 

 

43,311

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue, net of current portion

 

 

2,684

 

 

2,380

 

 

2,195

 

Income tax liability

 

 

394

 

 

352

 

 

379

 

Other long-term liabilities

 

 

553

 

 

640

 

 

460

 

 

 

Total liabilities

 

 

51,251

 

 

48,536

 

 

46,345

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

14

 

 

14

 

 

13

 

 

Additional paid-in capital

 

 

70,451

 

 

68,180

 

 

62,025

 

 

Accumulated income/(loss)

 

 

(24,010)

 

 

2,283

 

 

2,947

 

 

Accumulated other comprehensive loss

 

 

(69)

 

 

(74)

 

 

(92)

 

 

 

Total stockholders' equity

 

 

46,386

 

 

70,403

 

 

64,893

 

 

 

Total liabilities and stockholders' equity

 

$

97,637

 

$

118,939

 

$

111,238

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to the prior periods presented.


 

CUTERA, INC.

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

(in thousands, except per share data)

 

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

 

 

December 31,

 

December 31,

 

December 31,

 

December 31,

 

 

 

 

 

2018

 

2017(1)

 

2018

 

2017(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

$

  39,946

 

$

  42,972

 

$

  142,535

 

$

  132,660

 

 

Service

 

  5,523

 

 

  4,660

 

 

  20,185

 

 

  18,833

 

 

  Total net revenue

 

  45,469

 

 

  47,632

 

 

  162,720

 

 

  151,493

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

  19,967

 

 

  17,520

 

 

  66,843

 

 

  56,363

 

 

Service

 

  6,716

 

 

  2,779

 

 

  15,495

 

 

  9,020

 

 

  Total cost of revenue

 

  26,683

 

 

  20,299

 

 

  82,338

 

 

  65,383

 

 

 

 

Gross profit

 

  18,786

 

 

  27,333

 

 

  80,382

 

 

  86,110

 

 

 

 

Gross margin %

 

41%

 

 

57%

 

 

49%

 

 

57%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

  15,318

 

 

  15,362

 

 

  58,420

 

 

  52,070

 

 

 

Research and development

 

  3,464

 

 

  3,481

 

 

  14,359

 

 

  12,874

 

 

 

General and administrative

 

  5,494

 

 

  3,947

 

 

  20,995

 

 

  14,090

 

 

 

Lease termination income

 

  -

 

 

  -

 

 

  -

 

 

  (4,000)

 

 

 

 

Total operating expenses

 

  24,276

 

 

  22,790

 

 

  93,774

 

 

  75,034

 

 

Income (loss) from operations

 

  (5,490)

 

 

  4,543

 

 

  (13,392)

 

 

  11,076

 

 

Interest and other income (expense), net

 

  (44)

 

 

  138

 

 

  (123)

 

 

  884

 

 

Income (loss) before income taxes

 

  (5,534)

 

 

  4,681

 

 

  (13,515)

 

 

  11,960

 

 

Provision (benefit) for income taxes

 

  20,759

 

 

  (18,199)

 

 

  17,255

 

 

  (18,033)

 

 

Net income (loss)

$

  (26,293)

 

$

  22,880

 

$

  (30,770)

 

$

  29,993

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

  (1.89)

 

 $

  1.66

 

 $

  (2.23)

 

 $

  2.16

 

 

 

Diluted

$

  (1.89)

 

 $

  1.57

 

 $

  (2.23)

 

 $

  2.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares used in per share calculations:

 

 

 

 

 

 

 

 

 

Basic

 

  13,932

 

 

  13,744

 

 

  13,771

 

 

  13,873

 

 

 

Diluted

 

  13,932

 

 

  14,569

 

 

  13,771

 

 

  14,728

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to the prior periods presented.


 

CUTERA, INC.

 

CONSOLIDATED FINANCIAL HIGHLIGHTS

 

(in thousands, except percentage data)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

% Change

 

Twelve Months Ended

 

% Change

 

 

 

 

 

December 31,

 

 

December 31,

 

2018 Vs

 

December 31,

 

 

December 31,

 

2018 Vs

 

 

 

 

 

2018

 

 

2017(1)

 

2017

 

2018

 

 

2017(1)

 

2017

 

Revenue By Geography:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

28,265

 

 

$

30,524

 

-7%

 

$

101,862

 

 

$

94,581

 

+8%

 

 

 

International

 

 

17,204

 

 

 

17,108

 

+1%

 

 

60,858

 

 

 

56,912

 

+7%

 

 

 

Total Net Revenue

 

$

45,469

 

 

$

47,632

 

-5%

 

$

162,720

 

 

$

151,493

 

+7%

 

 

 

International as a percentage of total revenue

 

 

38%

 

 

 

36%

 

 

 

 

37%

 

 

 

38%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue By Product Category:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Systems

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- North America

 

$

26,519

 

 

$

29,383

 

-10%

 

$

93,977

 

 

$

88,338

 

+6%

 

 

 

- Rest of World

 

 

10,349

 

 

 

11,531

 

-10%

 

 

38,618

 

 

 

37,544

 

+3%

 

 

 

Total Systems

 

 

36,868

 

 

 

40,914

 

-10%

 

 

132,595

 

 

 

125,882

 

+5%

 

 

Consumables

 

 

1,281

 

 

 

692

 

+85%

 

 

4,162

 

 

 

2,436

 

+71%

 

 

Skincare

 

 

1,797

 

 

 

1,366

 

+32%

 

 

5,778

 

 

 

4,342

 

+33%

 

 

 

Total Products

 

 

39,946

 

 

 

42,972

 

-7%

 

 

142,535

 

 

 

132,660

 

+7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service

 

 

5,523

 

 

 

4,660

 

+19%

 

 

20,185

 

 

 

18,833

 

+7%

 

 

 

Total Net Revenue

 

$

45,469

 

 

$

47,632

 

-5%

 

$

162,720

 

 

$

151,493

 

+7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to the prior periods presented.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

Twelve Months Ended

 

 

 

 

 

 

 

December 31,

 

 

December 31,

 

 

 

December 31,

 

 

December 31,

 

 

 

 

 

 

 

2018

 

 

2017

 

 

 

2018

 

 

2017

 

 

 

Pre-tax Stock-Based Compensation Expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

167

 

 

$

283

 

 

 

$

743

 

 

$

660

 

 

 

 

 

Sales and marketing

 

 

360

 

 

 

427

 

 

 

 

2,104

 

 

 

1642

 

 

 

 

 

Research and development

 

 

208

 

 

 

303

 

 

 

 

825

 

 

 

936

 

 

 

 

 

General and administrative

 

 

897

 

 

 

474

 

 

 

 

3,484

 

 

 

1872

 

 

 

 

 

 

 

$

1,632

 

 

$

1,487

 

 

 

$

7,156

 

 

$

5,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

CUTERA, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(in thousands)

 

(unaudited)

 

 

 

 

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

 

 

December 31,

 

December 31,

 

 

December 31,

 

December 31,

 

 

 

 

 

2018

 

2017(1)

 

 

2018

 

2017(1)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

  (26,293)

 

$

  22,880

 

 

$

  (30,770)

 

$

  29,993

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

  1,632

 

 

  1,487

 

 

 

  7,156

 

 

  5,110

 

 

Depreciation of tangible assets

 

 

  360

 

 

  266

 

 

 

  1,209

 

 

  1,016

 

 

Amortization of contract acquisition costs

 

 

  530

 

 

  -

 

 

 

  1,834

 

 

  -

 

 

Change in deferred tax asset

 

 

  20,945

 

 

  (18,678)

 

 

 

  17,438

 

 

  (18,678)

 

 

Provision for doubtful accounts receivable

 

 

  380

 

 

  8

 

 

 

  1,257

 

 

  (1)

 

 

Other

 

 

  26

 

 

  7

 

 

 

  241

 

 

  (51)

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

  5,427

 

 

  (1,181)

 

 

 

  (117)

 

 

  (4,229)

 

 

Inventories

 

 

  3,308

 

 

  (5,054)

 

 

 

  768

 

 

  (13,805)

 

 

Other current assets and prepaid expenses

 

 

  (273)

 

 

  42

 

 

 

  (1,070)

 

 

  (591)

 

 

Other long-term assets

 

 

  (453)

 

 

  7

 

 

 

  (2,754)

 

 

  6

 

 

Accounts payable

 

 

  (2,042)

 

 

  1,197

 

 

 

  4,277

 

 

  4,404

 

 

Accrued liabilities

 

 

  396

 

 

  4,588

 

 

 

  (3,781)

 

 

  9,345

 

 

Extended warranty liabilities

 

 

  3,159

 

 

  -

 

 

 

  3,159

 

 

  -

 

 

Other long-term liabilities

 

 

  35

 

 

  -

 

 

 

  140

 

 

  -

 

 

Deferred revenue

 

 

  1,247

 

 

  905

 

 

 

  1,305

 

 

  1,557

 

 

Income tax liability

 

 

  42

 

 

  208

 

 

 

  15

 

 

  211

 

 

 

Net cash provided by operating activities

 

 

  8,426

 

 

  6,682

 

 

 

  307

 

 

  14,287

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition of property, equipment and software

 

 

  (274)

 

 

  (412)

 

 

 

  (1,488)

 

 

  (855)

 

Disposal of property and equipment

 

 

  -

 

 

  -

 

 

 

  41

 

 

  53

 

Proceeds from sales of marketable investments

 

 

  -

 

 

  24,486

 

 

 

  13,044

 

 

  33,640

 

Proceeds from maturities of marketable investments

 

 

  2,000

 

 

  6,200

 

 

 

  10,050

 

 

  45,812

 

Purchase of marketable investments

 

 

  (6,484)

 

 

  (16,800)

 

 

 

  (10,874)

 

 

  (60,956)

 

 

 

Net cash provided by (used in) investing activities

 

 

  (4,758)

 

 

  13,474

 

 

 

  10,773

 

 

  17,694

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases of common stock

 

 

  -

 

 

  (21,391)

 

 

 

  -

 

 

  (35,167)

 

Proceeds from exercise of stock options and employee stock purchase plan

 

 

  796

 

 

  869

 

 

 

  4,399

 

 

  5,435

 

Taxes paid related to net share settlement of equity awards

 

 

  (157)

 

 

  (137)

 

 

 

  (3,128)

 

 

  (1,469)

 

Payments on capital lease obligations

 

 

  (121)

 

 

  (97)

 

 

 

  (483)

 

 

  (371)

 

 

 

Net cash provided by (used in) financing activities

 

 

  518

 

 

  (20,756)

 

 

 

  788

 

 

  (31,572)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

 

  4,186

 

 

  (600)

 

 

 

  11,868

 

 

  409

 

Cash and cash equivalents at beginning of period

 

 

  21,866

 

 

  14,784

 

 

 

  14,184

 

 

  13,775

 

Cash and cash equivalents at end of period

 

$

  26,052

 

 $

  14,184

 

 

$

  26,052

 

 $

  14,184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to the prior periods presented.


 

CUTERA, INC.

 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(in thousands, except per share data)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2018

 

Three Months Ended December 31, 2017

 

 

 

 

 

GAAP

 

Adjustments*

 

Non-GAAP

 

GAAP(1)

 

Adjustments*

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

 $  45,469

 

 $  -

 

 

 $  45,469

 

 $  47,632

 

 $  -

 

 

 $  47,632

 

Cost of revenue

 

  26,683

 

  (5,217)

 (a)

 

  21,466

 

  20,299

 

  (377)

 (a)

 

  19,922

 

 

 

Gross profit

 

  18,786

 

  5,217

 

 

  24,003

 

  27,333

 

  377

 

 

  27,710

 

 

 

Gross margin %

 

41%

 

 

 

 

53%

 

57%

 

 

 

 

58%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

  15,318

 

  (1,052)

 (b)

 

  14,266

 

  15,362

 

  (586)

 (b)

 

  14,776

 

 

Research and development

 

  3,464

 

  (231)

 (c)

 

  3,233

 

  3,481

 

  (314)

 (c)

 

  3,167

 

 

General and administrative

 

  5,494

 

  (1,194)

 (d)

 

  4,300

 

  3,947

 

  (476)

 (d)

 

  3,471

 

 

 

Total operating expenses

 

  24,276

 

  (2,477)

 

 

  21,799

 

  22,790

 

  (1,376)

 

 

  21,414

 

Income (loss) from operations 

 

  (5,490)

 

  7,694

 

 

  2,204

 

  4,543

 

  1,753

 

 

  6,296

 

Interest and other income (expense), net

 

  (44)

 

   -

 

 

  (44)

 

  138

 

  -

 

 

  138

 

Income (loss) before income taxes

 

  (5,534)

 

  7,694

 

 

  2,160

 

  4,681

 

  1,753

 

 

  6,434

 

Provision (benefit) for income taxes

 

  20,759

 

  (17,037)

 (e)

 

  3,722

 

  (18,199)

 

  18,491

 (e)

 

  292

 

Net income (loss)

 

 $  (26,293)

 

 $  24,731

 

 

 $  (1,562)

 

 $  22,880

 

 $  (16,738)

 

 

 $  6,142

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $  (1.89)

 

 

 

 

 $  (0.11)

 

 $  1.66

 

 

 

 

 $  0.45

 

 

Diluted

 

 $  (1.89)

 

 

 

 

 $  (0.11)

 

 $  1.57

 

 

 

 

 $  0.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

  13,932

 

 

 

 

  13,932

 

  13,744

 

 

 

 

  13,744

 

 

Diluted

 

  13,932

 

 

 

 

  13,932

 

  14,569

 

 

 

 

  14,569

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to
  the prior periods presented.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses as a % of net revenue 

 

GAAP

 

 

 

 

Non-GAAP

 

GAAP(1)

 

 

 

 

Non-GAAP

 

 

Sales and marketing 

 

33.7%

 

 

 

 

31.4%

 

32.3%

 

 

 

 

31.0%

 

 

Research and development 

 

7.6%

 

 

 

 

7.1%

 

7.3%

 

 

 

 

6.6%

 

 

General and administrative 

 

12.1%

 

 

 

 

9.5%

 

8.3%

 

 

 

 

7.3%

 

 

 

 

 

53.4%

 

 

 

 

47.9%

 

47.8%

 

 

 

 

45.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* Fiscal fourth quarter of 2018 and 2017 Non-GAAP results exclude the effect of the below mentioned adjustments ($000s): 

 

a)

Adjustment of $5,217 and $377 for 2018 and 2017, respectively, included non-cash expenses of $94 and $94 related to depreciation, and $167 and $283 of stock-based compensation.  The 2018 adjustment also included $4,956 related to a component replacement in one of our legacy systems.

 

b)

Adjustment of $1,052 and $586 for 2018 and 2017, respectively, included non-cash expenses of $692 and $159 related to depreciation and amortization, and $360 and $427 of stock-based compensation.

 

c)

Adjustment of $231 and $314 for 2018 and 2017, respectively, included non-cash expenses of $23 and $11 related to depreciation, and $208 and $303 of stock-based compensation.

 

d)

Adjustment of $1,194 and $476 for 2018 and 2017, respectively, included non-cash expenses of $81 and $2 related to depreciation and $897 and $474 for stock-based  compensation.  The 2018 adjustment also included $216 for costs related to ERP implementation.

 

e)

The 2018 adjustment of $17,037 included recording a valuation allowance of $16,906 against certain U.S. deferred tax assets and net impact of excluding the Non-GAAP adjustments from our tax provision.  As a result of recording a valuation allowance in Q4'2018, the 2018 adjustment also includes the reversal of $2.85M in discrete tax benefits related to excess stock deduction activity for the nine months ended September 30, 2018.  The 2017 adjustment of ($18,491) included $18,741 for the release of a significant portion of our valuation allowance against certain U.S. deferred tax assets, partially offset by our revised measurement of U.S. deferred tax assets resulting from the 2017 US Tax Reform; offset by $248 for establishing a foreign transfer pricing contingency reserve and the net impact of excluding the Non-GAAP adjustments from our tax provision.


 

CUTERA, INC.

 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(in thousands, except per share data)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months Ended December 31, 2018

 

Twelve Months Ended December 31, 2017

 

 

 

 

 

GAAP

 

Adjustments*

 

Non-GAAP

 

GAAP(1)

 

Adjustments*

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

 $  162,720

 

 $  -

 

 

 $  162,720

 

 $  151,493

 

 $  -

 

 

 $  151,493

 

Cost of revenue

 

  82,338

 

  (6,018)

 (a)

 

  76,320

 

  65,383

 

  (989)

 (a)

 

  64,394

 

 

 

Gross profit

 

  80,382

 

  6,018

 

 

  86,400

 

  86,110

 

  989

 

 

  87,099

 

 

 

Gross margin %

 

49%

 

 

 

 

53%

 

57%

 

 

 

 

57%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

  58,420

 

  (4,562)

 (b)

 

  53,858

 

  52,070

 

  (2,300)

 (b)

 

  49,770

 

 

Research and development

 

  14,359

 

  (899)

 (c)

 

  13,460

 

  12,874

 

  (961)

 (c)

 

  11,913

 

 

General and administrative

 

  20,995

 

  (3,892)

 (d)

 

  17,103

 

  14,090

 

  (1,876)

 (d)

 

  12,214

 

 

Lease termination income

 

  -

 

  -

 

 

  -

 

  (4,000)

 

  4,000

 (e)

 

  -

 

 

 

Total operating expenses

 

  93,774

 

  (9,353)

 

 

  84,421

 

  75,034

 

  (1,137)

 

 

  73,897

 

Income (loss) from operations

 

 

  (13,392)

 

  15,371

 

 

  1,979

 

  11,076

 

  2,126

 

 

  13,202

 

Interest and other income (expense), net

 

  (123)

 

   -

 

 

  (123)

 

  884

 

  -

 

 

  884

 

Income (loss) before income taxes

 

  (13,515)

 

  15,371

 

 

  1,856

 

  11,960

 

  2,126

 

 

  14,086

 

Provision (benefit) for income taxes

 

  17,255

 

   (16,906)

 (f)

 

  349

 

  (18,033)

 

  18,411

 (f)

 

  378

 

Net income (loss)

 

 $  (30,770)

 

 $  32,277

 

 

 $  1,507

 

 $  29,993

 

 $  (16,285)

 

 

 $  13,708

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $  (2.23)

 

 

 

 

 $  0.11

 

 $  2.16

 

 

 

 

 $  0.99

 

 

Diluted

 

 $  (2.23)

 

 

 

 

 $  0.11

 

 $  2.04

 

 

 

 

 $  0.93

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

  13,771

 

 

 

 

  13,771

 

  13,873

 

 

 

 

  13,873

 

 

Diluted

 

  13,771

 

 

 

 

  14,305

 

  14,728

 

 

 

 

  14,728

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective method, and as a result, there is a lack of comparability to the prior periods presented.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses as a % of net revenue 

 

GAAP

 

 

 

 

Non-GAAP

 

GAAP(1)

 

 

 

 

Non-GAAP

 

 

Sales and marketing 

 

35.9%

 

 

 

 

33.1%

 

34.4%

 

 

 

 

32.9%

 

 

Research and development 

 

8.8%

 

 

 

 

8.3%

 

8.5%

 

 

 

 

7.9%

 

 

General and administrative 

 

12.9%

 

 

 

 

10.5%

 

9.3%

 

 

 

 

8.1%

 

 

Lease termination income 

 

0.0%

 

 

 

 

0.0%

 

-2.6%

 

 

 

 

0.0%

 

 

 

 

 

57.6%

 

 

 

 

51.9%

 

49.5%

 

 

 

 

48.8%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* Year-to-date December 31, 2018 and 2017 Non-GAAP results exclude the effect of the below mentioned adjustments ($000s): 

 

a)

Adjustment of $6,018 and $989 for 2018 and 2017, respectively, included non-cash expenses of $319 and $329 related to depreciation, and $743 and $660 of stock-based compensation.  The 2018 adjustment also included $4,956 recorded in Q4'2018 related to a component replacement in one of our legacy systems.

 

b)

Adjustment of $4,562 and $2,300 for 2018 and 2017, respectively, included non-cash expenses of $2,458 and $658 related to depreciation and amortization, and $2,104 and $1,642 of stock-based compensation.

 

c)

Adjustment of $899 and $961 for 2018 and 2017, respectively, included non-cash expenses of $74 and $25 related to depreciation, and $825 and $936 of stock-based compensation.

 

d)

Adjustment of $3,892 and $1,876 for 2018 and 2017, respectively, included non-cash expenses of $192 and $4 related to depreciation and $3,484 and $1,872 for stock-based compensation. The 2018 adjustment also included $216 for costs related to ERP implementation.

 

e)

Adjustment of $4,000 represents non-recurring lease termination income.

 

f)

The 2018 adjustment of $16,906 represents a valuation allowance against certain U.S. deferred tax assets.  The 2017 adjustment of ($18,411) included $18,741 for the release of a significant portion of our valuation allowance against certain U.S. deferred tax assets, partially offset by our revised measurement of U.S. deferred tax assets resulting from the 2017 US Tax Reform; offset by $248 for establishing a foreign transfer pricing contingency reserve and the net impact of excluding the Non-GAAP adjustments from our tax provision.